Baxter Bros’s VALEANT PHARMACEUTICALS INTL VRX Stock Holding History
Bought
Maintained
Sold
Baxter Bros's VRX Position: Q3 2018 in Review
Baxter Bros sold out of VALEANT PHARMACEUTICALS INTL (VRX) in Q3 2018, closing a stake of 15,900 shares — an estimated $370K sold.
Baxter Bros first reported a position in VRX in Q1 2017 and held it in 6 quarters. The position peaked at $545K in Q2 2017. 0 funds tracked by Wall St. Rank hold VRX as of Q3 2018.
- Baxter Bros reported no remaining VALEANT PHARMACEUTICALS INTL position as of Q3 2018 after selling out during the quarter.
- Baxter Bros sold 15,900 VALEANT PHARMACEUTICALS INTL shares in Q3 2018, an estimated $370K.
- Baxter Bros first reported a position in VALEANT PHARMACEUTICALS INTL in Q1 2017 and held it in 6 quarters.
- Baxter Bros's VALEANT PHARMACEUTICALS INTL position peaked at $545K in Q2 2017.
- 0 funds tracked by Wall St. Rank held VALEANT PHARMACEUTICALS INTL as of Q3 2018.
Based on Baxter Bros's 13F filing for Q3 2018, filed 11 Oct 2018.